Loading…

Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes

Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellu...

Full description

Saved in:
Bibliographic Details
Published in:Human & experimental toxicology 2019-11, Vol.38 (11), p.1266-1274
Main Authors: Salimi, A, Pirhadi, R, Jamali, Z, Ramazani, M, Yousefsani, BS, Pourahmad, J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3
cites cdi_FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3
container_end_page 1274
container_issue 11
container_start_page 1266
container_title Human & experimental toxicology
container_volume 38
creator Salimi, A
Pirhadi, R
Jamali, Z
Ramazani, M
Yousefsani, BS
Pourahmad, J
description Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellular parameters assays such as cellular viability, reactive oxygen species (ROS) formation, mitochondrial membrane permeability transition (mitochondrial membrane potential (MMP)) collapse, lysosomal membrane damage, intracellular reduced glutathione (GSH), extracellular oxidized glutathione (GSSG), and lipid peroxidation. Separately, human lymphocytes were treated with concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 ng/mL for CYP and 1, 2, 5, and 10 µg/mL for MTX for 6 h. Statistical evaluations showed that CYP and MTX significantly decreased the cell viability at the three highest concentrations when compared with both the negative and solvent controls. In addition, CYP and MTX were significantly induced ROS formation, MMP collapse, lysosomal membrane damage, lipid peroxidation, and GSH depletion compared with the controls. Mitochondrial and lysosomal protective agents like cyclosporine A and chloroquine, respectively, decreased cytotoxicity and oxidative stress induced by CYP and MTX. The present results indicate that CYP and MTX are toxic to human PBLs and their toxicity could be ameliorated by mitochondrial and lysosomal protective agents.
doi_str_mv 10.1177/0960327119871096
format article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_journals_2287031624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0960327119871096</sage_id><sourcerecordid>2287031624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhS0EoreFPSsUiXXAEzt2skQVf1IRG1hHE3tCXCXxxXZQ8zo8Kc69pUhIrOzRfOecsYexF8BfA2j9hreKi0oDtI2GXDxiB5Bal7zl4jE77O1y71-wyxhvOeeqreEpuxAgpdKNPLBfn13yZvSLDQ6nAhdbTFv00c-5OgafyCT3kwr8TkuKBc40OR8wUWG25JO_c8al7aTLd4snOKZAMRZusashW_Rbhs3kj6OPxxFnZ-kkmCmNPqN3u51binGdcSn6yft9iDnjOYPiM_ZkwCnS8_vzin17_-7r9cfy5suHT9dvb0ojVJ1KGDT21ALHWjUADfVcctFKW9OgBB9Aix7JVqgUIRLWpu8lSKokWDSaxBV7dfbNz_6xUkzdrV_DkiO7qmo0F6AqmSl-pkzwMQYaumNwM4atA97tS-n-XUqWvLw3XvuZ7IPgzxYyUJ6BmL_5b-p_DX8DMrCaAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2287031624</pqid></control><display><type>article</type><title>Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes</title><source>Sage Journals GOLD Open Access 2024</source><creator>Salimi, A ; Pirhadi, R ; Jamali, Z ; Ramazani, M ; Yousefsani, BS ; Pourahmad, J</creator><creatorcontrib>Salimi, A ; Pirhadi, R ; Jamali, Z ; Ramazani, M ; Yousefsani, BS ; Pourahmad, J</creatorcontrib><description>Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellular parameters assays such as cellular viability, reactive oxygen species (ROS) formation, mitochondrial membrane permeability transition (mitochondrial membrane potential (MMP)) collapse, lysosomal membrane damage, intracellular reduced glutathione (GSH), extracellular oxidized glutathione (GSSG), and lipid peroxidation. Separately, human lymphocytes were treated with concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 ng/mL for CYP and 1, 2, 5, and 10 µg/mL for MTX for 6 h. Statistical evaluations showed that CYP and MTX significantly decreased the cell viability at the three highest concentrations when compared with both the negative and solvent controls. In addition, CYP and MTX were significantly induced ROS formation, MMP collapse, lysosomal membrane damage, lipid peroxidation, and GSH depletion compared with the controls. Mitochondrial and lysosomal protective agents like cyclosporine A and chloroquine, respectively, decreased cytotoxicity and oxidative stress induced by CYP and MTX. The present results indicate that CYP and MTX are toxic to human PBLs and their toxicity could be ameliorated by mitochondrial and lysosomal protective agents.</description><identifier>ISSN: 0960-3271</identifier><identifier>EISSN: 1477-0903</identifier><identifier>DOI: 10.1177/0960327119871096</identifier><identifier>PMID: 31446784</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adolescent ; Adult ; Antineoplastic Agents - toxicity ; Blood ; Butylated Hydroxytoluene - pharmacology ; Cell Survival - drug effects ; Cell viability ; Cells, Cultured ; Chloroquine ; Chloroquine - pharmacology ; Collapse ; Cyclophosphamide ; Cyclophosphamide - toxicity ; Cyclosporine - pharmacology ; Cyclosporins ; Cytotoxicity ; Depletion ; Glutathione ; Glutathione - metabolism ; Humans ; Immunosuppressive Agents - toxicity ; Lipid peroxidation ; Lipids ; Lymphocytes ; Lymphocytes - drug effects ; Lymphocytes - metabolism ; Lysosomes - drug effects ; Membrane permeability ; Membrane potential ; Methotrexate ; Methotrexate - toxicity ; Mitochondria ; Mitochondria - drug effects ; Mitochondria - physiology ; Oxidation ; Oxidative stress ; Oxidative Stress - drug effects ; Peripheral blood ; Peroxidation ; Protective Agents - pharmacology ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Stabilizers (agents) ; Toxicity ; Young Adult</subject><ispartof>Human &amp; experimental toxicology, 2019-11, Vol.38 (11), p.1266-1274</ispartof><rights>The Author(s) 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3</citedby><cites>FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3</cites><orcidid>0000-0003-3026-6398 ; 0000-0002-4555-4168</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0960327119871096$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0960327119871096$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21966,27853,27924,27925,44945,45333</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/0960327119871096?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31446784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salimi, A</creatorcontrib><creatorcontrib>Pirhadi, R</creatorcontrib><creatorcontrib>Jamali, Z</creatorcontrib><creatorcontrib>Ramazani, M</creatorcontrib><creatorcontrib>Yousefsani, BS</creatorcontrib><creatorcontrib>Pourahmad, J</creatorcontrib><title>Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes</title><title>Human &amp; experimental toxicology</title><addtitle>Hum Exp Toxicol</addtitle><description>Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellular parameters assays such as cellular viability, reactive oxygen species (ROS) formation, mitochondrial membrane permeability transition (mitochondrial membrane potential (MMP)) collapse, lysosomal membrane damage, intracellular reduced glutathione (GSH), extracellular oxidized glutathione (GSSG), and lipid peroxidation. Separately, human lymphocytes were treated with concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 ng/mL for CYP and 1, 2, 5, and 10 µg/mL for MTX for 6 h. Statistical evaluations showed that CYP and MTX significantly decreased the cell viability at the three highest concentrations when compared with both the negative and solvent controls. In addition, CYP and MTX were significantly induced ROS formation, MMP collapse, lysosomal membrane damage, lipid peroxidation, and GSH depletion compared with the controls. Mitochondrial and lysosomal protective agents like cyclosporine A and chloroquine, respectively, decreased cytotoxicity and oxidative stress induced by CYP and MTX. The present results indicate that CYP and MTX are toxic to human PBLs and their toxicity could be ameliorated by mitochondrial and lysosomal protective agents.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Blood</subject><subject>Butylated Hydroxytoluene - pharmacology</subject><subject>Cell Survival - drug effects</subject><subject>Cell viability</subject><subject>Cells, Cultured</subject><subject>Chloroquine</subject><subject>Chloroquine - pharmacology</subject><subject>Collapse</subject><subject>Cyclophosphamide</subject><subject>Cyclophosphamide - toxicity</subject><subject>Cyclosporine - pharmacology</subject><subject>Cyclosporins</subject><subject>Cytotoxicity</subject><subject>Depletion</subject><subject>Glutathione</subject><subject>Glutathione - metabolism</subject><subject>Humans</subject><subject>Immunosuppressive Agents - toxicity</subject><subject>Lipid peroxidation</subject><subject>Lipids</subject><subject>Lymphocytes</subject><subject>Lymphocytes - drug effects</subject><subject>Lymphocytes - metabolism</subject><subject>Lysosomes - drug effects</subject><subject>Membrane permeability</subject><subject>Membrane potential</subject><subject>Methotrexate</subject><subject>Methotrexate - toxicity</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - physiology</subject><subject>Oxidation</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Peripheral blood</subject><subject>Peroxidation</subject><subject>Protective Agents - pharmacology</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Stabilizers (agents)</subject><subject>Toxicity</subject><subject>Young Adult</subject><issn>0960-3271</issn><issn>1477-0903</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1TAQhS0EoreFPSsUiXXAEzt2skQVf1IRG1hHE3tCXCXxxXZQ8zo8Kc69pUhIrOzRfOecsYexF8BfA2j9hreKi0oDtI2GXDxiB5Bal7zl4jE77O1y71-wyxhvOeeqreEpuxAgpdKNPLBfn13yZvSLDQ6nAhdbTFv00c-5OgafyCT3kwr8TkuKBc40OR8wUWG25JO_c8al7aTLd4snOKZAMRZusashW_Rbhs3kj6OPxxFnZ-kkmCmNPqN3u51binGdcSn6yft9iDnjOYPiM_ZkwCnS8_vzin17_-7r9cfy5suHT9dvb0ojVJ1KGDT21ALHWjUADfVcctFKW9OgBB9Aix7JVqgUIRLWpu8lSKokWDSaxBV7dfbNz_6xUkzdrV_DkiO7qmo0F6AqmSl-pkzwMQYaumNwM4atA97tS-n-XUqWvLw3XvuZ7IPgzxYyUJ6BmL_5b-p_DX8DMrCaAw</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Salimi, A</creator><creator>Pirhadi, R</creator><creator>Jamali, Z</creator><creator>Ramazani, M</creator><creator>Yousefsani, BS</creator><creator>Pourahmad, J</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>SOI</scope><orcidid>https://orcid.org/0000-0003-3026-6398</orcidid><orcidid>https://orcid.org/0000-0002-4555-4168</orcidid></search><sort><creationdate>201911</creationdate><title>Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes</title><author>Salimi, A ; Pirhadi, R ; Jamali, Z ; Ramazani, M ; Yousefsani, BS ; Pourahmad, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Blood</topic><topic>Butylated Hydroxytoluene - pharmacology</topic><topic>Cell Survival - drug effects</topic><topic>Cell viability</topic><topic>Cells, Cultured</topic><topic>Chloroquine</topic><topic>Chloroquine - pharmacology</topic><topic>Collapse</topic><topic>Cyclophosphamide</topic><topic>Cyclophosphamide - toxicity</topic><topic>Cyclosporine - pharmacology</topic><topic>Cyclosporins</topic><topic>Cytotoxicity</topic><topic>Depletion</topic><topic>Glutathione</topic><topic>Glutathione - metabolism</topic><topic>Humans</topic><topic>Immunosuppressive Agents - toxicity</topic><topic>Lipid peroxidation</topic><topic>Lipids</topic><topic>Lymphocytes</topic><topic>Lymphocytes - drug effects</topic><topic>Lymphocytes - metabolism</topic><topic>Lysosomes - drug effects</topic><topic>Membrane permeability</topic><topic>Membrane potential</topic><topic>Methotrexate</topic><topic>Methotrexate - toxicity</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - physiology</topic><topic>Oxidation</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Peripheral blood</topic><topic>Peroxidation</topic><topic>Protective Agents - pharmacology</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Stabilizers (agents)</topic><topic>Toxicity</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salimi, A</creatorcontrib><creatorcontrib>Pirhadi, R</creatorcontrib><creatorcontrib>Jamali, Z</creatorcontrib><creatorcontrib>Ramazani, M</creatorcontrib><creatorcontrib>Yousefsani, BS</creatorcontrib><creatorcontrib>Pourahmad, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Environment Abstracts</collection><jtitle>Human &amp; experimental toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Salimi, A</au><au>Pirhadi, R</au><au>Jamali, Z</au><au>Ramazani, M</au><au>Yousefsani, BS</au><au>Pourahmad, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes</atitle><jtitle>Human &amp; experimental toxicology</jtitle><addtitle>Hum Exp Toxicol</addtitle><date>2019-11</date><risdate>2019</risdate><volume>38</volume><issue>11</issue><spage>1266</spage><epage>1274</epage><pages>1266-1274</pages><issn>0960-3271</issn><eissn>1477-0903</eissn><abstract>Cyclophosphamide (CYP) and methotrexate (MTX) have been evaluated for their ability to induce toxicity in human peripheral blood lymphocytes (PBLs) and the protective role of mitochondrial and lysosomal stabilizing agents. The potential toxicity effects of CYP and MTX were measured in vitro by cellular parameters assays such as cellular viability, reactive oxygen species (ROS) formation, mitochondrial membrane permeability transition (mitochondrial membrane potential (MMP)) collapse, lysosomal membrane damage, intracellular reduced glutathione (GSH), extracellular oxidized glutathione (GSSG), and lipid peroxidation. Separately, human lymphocytes were treated with concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 ng/mL for CYP and 1, 2, 5, and 10 µg/mL for MTX for 6 h. Statistical evaluations showed that CYP and MTX significantly decreased the cell viability at the three highest concentrations when compared with both the negative and solvent controls. In addition, CYP and MTX were significantly induced ROS formation, MMP collapse, lysosomal membrane damage, lipid peroxidation, and GSH depletion compared with the controls. Mitochondrial and lysosomal protective agents like cyclosporine A and chloroquine, respectively, decreased cytotoxicity and oxidative stress induced by CYP and MTX. The present results indicate that CYP and MTX are toxic to human PBLs and their toxicity could be ameliorated by mitochondrial and lysosomal protective agents.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>31446784</pmid><doi>10.1177/0960327119871096</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-3026-6398</orcidid><orcidid>https://orcid.org/0000-0002-4555-4168</orcidid></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0960-3271
ispartof Human & experimental toxicology, 2019-11, Vol.38 (11), p.1266-1274
issn 0960-3271
1477-0903
language eng
recordid cdi_proquest_journals_2287031624
source Sage Journals GOLD Open Access 2024
subjects Adolescent
Adult
Antineoplastic Agents - toxicity
Blood
Butylated Hydroxytoluene - pharmacology
Cell Survival - drug effects
Cell viability
Cells, Cultured
Chloroquine
Chloroquine - pharmacology
Collapse
Cyclophosphamide
Cyclophosphamide - toxicity
Cyclosporine - pharmacology
Cyclosporins
Cytotoxicity
Depletion
Glutathione
Glutathione - metabolism
Humans
Immunosuppressive Agents - toxicity
Lipid peroxidation
Lipids
Lymphocytes
Lymphocytes - drug effects
Lymphocytes - metabolism
Lysosomes - drug effects
Membrane permeability
Membrane potential
Methotrexate
Methotrexate - toxicity
Mitochondria
Mitochondria - drug effects
Mitochondria - physiology
Oxidation
Oxidative stress
Oxidative Stress - drug effects
Peripheral blood
Peroxidation
Protective Agents - pharmacology
Reactive oxygen species
Reactive Oxygen Species - metabolism
Stabilizers (agents)
Toxicity
Young Adult
title Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A57%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20and%20lysosomal%20protective%20agents%20ameliorate%20cytotoxicity%20and%20oxidative%20stress%20induced%20by%20cyclophosphamide%20and%20methotrexate%20in%20human%20blood%20lymphocytes&rft.jtitle=Human%20&%20experimental%20toxicology&rft.au=Salimi,%20A&rft.date=2019-11&rft.volume=38&rft.issue=11&rft.spage=1266&rft.epage=1274&rft.pages=1266-1274&rft.issn=0960-3271&rft.eissn=1477-0903&rft_id=info:doi/10.1177/0960327119871096&rft_dat=%3Cproquest_AFRWT%3E2287031624%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-1f7abe910a568118eb040394d5ef630f173baed2a66eaaea5cbb414e241dac7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2287031624&rft_id=info:pmid/31446784&rft_sage_id=10.1177_0960327119871096&rfr_iscdi=true